BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
BD (NYSE:BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional ...
Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.
Global medtech giant BD announced that it is adding capacity to its US-based footprint for the production of critical medical devices, including syringes, needles, and IV catheters. As part of the ...
Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...
FRANKLIN LAKES, N.J., Jan. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company ... for critical medical devices, including syringes, needles and IV catheters, to meet the ongoing needs ...
As part of the company’s 2024 investment of more than $10M to expand manufacturing capacity, new needle and ... % and conventional syringes by more than 50%. In addition, BD has hired more ...
including syringes, needles and IV catheters, to meet the ongoing needs of the nation's health care system. These new lines will boost BD's capacity of domestically manufactured safety-engineered ...
including syringes, needles and IV catheters, to meet the ongoing needs of the nation's health care system. These new lines will boost BD's capacity of domestically manufactured safety-engineered ...